{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T21:49:11Z","timestamp":1793742551984,"version":"4.6.1"},"reference-count":45,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["international-journal-of-gynecological-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Gynecological Cancer"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1136\/ijgc-2018-000036","type":"journal-article","created":{"date-parts":[[2019,1,14]],"date-time":"2019-01-14T14:11:48Z","timestamp":1547475108000},"page":"77-85","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":64,"title":["Pregnancy and oncologic outcomes after fertility-sparing management for early stage endometrioid endometrial cancer"],"prefix":"10.1016","volume":"29","author":[{"given":"Su Hyun","family":"Chae","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung-Hyuk","family":"Shim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sun Joo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji Young","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soo-Nyung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soon-Beom","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1136\/ijgc-2018-000036_bb0010","first-page":"9","article-title":"Cancer statistics, 2014","volume":"64","author":"Siegel","year":"2014","journal-title":"CA Cancer J Clin"},{"key":"10.1136\/ijgc-2018-000036_bb0015","doi-asserted-by":"crossref","first-page":"e84","DOI":"10.3802\/jgo.2017.28.e84","article-title":"Impact of vaginal cylinder diameter on outcomes following brachytherapy for early stage endometrial cancer","volume":"28","author":"Qian","year":"2017","journal-title":"J Gynecol Oncol"},{"key":"10.1136\/ijgc-2018-000036_bb0020","doi-asserted-by":"crossref","first-page":"298","DOI":"10.3802\/jgo.2013.24.4.298","article-title":"Incidence of cervical, endometrial, and ovarian cancer in Korea, 1999-2010","volume":"24","author":"Lim","year":"2013","journal-title":"J Gynecol Oncol"},{"key":"10.1136\/ijgc-2018-000036_bb0025","doi-asserted-by":"crossref","first-page":"303","DOI":"10.4143\/crt.2018.143","article-title":"Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2015","volume":"50","author":"Jung","year":"2018","journal-title":"Cancer Res Treat"},{"key":"10.1136\/ijgc-2018-000036_bb0030","doi-asserted-by":"crossref","first-page":"e12","DOI":"10.3802\/jgo.2017.28.e12","article-title":"Practice guidelines for management of uterine corpus cancer in Korea: a Korean Society of Gynecologic Oncology Consensus Statement","volume":"28","author":"Lee","year":"2017","journal-title":"J Gynecol Oncol"},{"key":"10.1136\/ijgc-2018-000036_bb0035","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1097\/01.AOG.0000255980.88205.15","article-title":"Prognostic factors for uterine cancer in reproductive-aged women","volume":"109","author":"Lee","year":"2007","journal-title":"Obstet Gynecol"},{"key":"10.1136\/ijgc-2018-000036_bb0040","first-page":"47","article-title":"Carcinoma of the corpus uteri","volume":"6","author":"Creasman","year":"2001","journal-title":"J Epidemiol Biostat"},{"key":"10.1136\/ijgc-2018-000036_bb0045","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.ygyno.2004.11.041","article-title":"Pre-operative imaging, surgery and adjuvant therapy for women diagnosed with cancer of the corpus uteri in community practice in the United States","volume":"96","author":"Trimble","year":"2005","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2018-000036_bb0050","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1111\/j.1600-0412.2012.01438.x","article-title":"Survival after stage IA endometrial cancer; can follow-up be altered? A prospective nationwide Danish survey","volume":"91","author":"Lajer","year":"2012","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1136\/ijgc-2018-000036_bb0055","doi-asserted-by":"crossref","first-page":"547.e1","DOI":"10.1016\/j.ajog.2010.07.037","article-title":"Oral progestogens vs levonorgestrel-releasing intrauterine system for endometrial hyperplasia: a systematic review and metaanalysis","volume":"203","author":"Gallos","year":"2010","journal-title":"Am J Obstet Gynecol"},{"key":"10.1136\/ijgc-2018-000036_bb0060","first-page":"718","article-title":"Outcome of fertility-sparing treatment with progestins in young patients with endometrial cancer","volume":"102","author":"Gotlieb","year":"2003","journal-title":"Obstet Gynecol"},{"key":"10.1136\/ijgc-2018-000036_bb0065","first-page":"673","article-title":"Conservative treatment with medroxyprogesterone acetate plus levonorgestrel intrauterine system for early-stage endometrial cancer in young women: pilot study","volume":"21","author":"Kim","year":"2011","journal-title":"Int J Gynecol Cancer"},{"key":"10.1136\/ijgc-2018-000036_bb0070","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1002\/(SICI)1097-0142(19970115)79:2<320::AID-CNCR15>3.0.CO;2-2","article-title":"Progestin alone as primary treatment of endometrial carcinoma in premenopausal women. Report of seven cases and review of the literature","volume":"79","author":"Kim","year":"1997","journal-title":"Cancer"},{"key":"10.1136\/ijgc-2018-000036_bb0075","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.fertnstert.2013.11.028","article-title":"Prognostic factors of oncologic and reproductive outcomes in fertility-sparing management of endometrial atypical hyperplasia and adenocarcinoma: systematic review and meta-analysis","volume":"101","author":"Koskas","year":"2014","journal-title":"Fertil Steril"},{"key":"10.1136\/ijgc-2018-000036_bb0080","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1159\/000209324","article-title":"Fertility-sparing in endometrial cancer","volume":"67","author":"Tangjitgamol","year":"2009","journal-title":"Gynecol Obstet Invest"},{"key":"10.1136\/ijgc-2018-000036_bb0085","doi-asserted-by":"crossref","first-page":"2798","DOI":"10.1200\/JCO.2006.08.8344","article-title":"Multicenter phase II study of fertility-sparing treatment with medroxyprogesterone acetate for endometrial carcinoma and atypical hyperplasia in young women","volume":"25","author":"Ushijima","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1136\/ijgc-2018-000036_bb0090","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.ygyno.2011.11.043","article-title":"Efficacy of oral or intrauterine device-delivered progestin in patients with complex endometrial hyperplasia with atypia or early endometrial adenocarcinoma: a meta-analysis and systematic review of the literature","volume":"125","author":"Baker","year":"2012","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2018-000036_bb0095","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/S0015-0282(01)02937-5","article-title":"Two successful pregnancies after conservative treatment of endometrial cancer and assisted reproduction","volume":"77","author":"Lowe","year":"2002","journal-title":"Fertil Steril"},{"key":"10.1136\/ijgc-2018-000036_bb0100","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s00404-011-1959-x","article-title":"Effectiveness of high-dose progestin and long-term outcomes in young women with early-stage, well-differentiated endometrioid adenocarcinoma of uterine endometrium","volume":"285","author":"Park","year":"2012","journal-title":"Arch Gynecol Obstet"},{"key":"10.1136\/ijgc-2018-000036_bb0105","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.ygyno.2004.06.045","article-title":"Hormonal therapy for the management of grade 1 endometrial adenocarcinoma: a literature review","volume":"95","author":"Ramirez","year":"2004","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2018-000036_bb0110","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s12958-015-0136-7","article-title":"Factors affecting pregnancy outcomes in young women treated with fertility-preserving therapy for well-differentiated endometrial cancer or atypical endometrial hyperplasia","volume":"14","author":"Inoue","year":"2016","journal-title":"Reprod Biol Endocrinol"},{"key":"10.1136\/ijgc-2018-000036_bb0115","doi-asserted-by":"crossref","first-page":"28","DOI":"10.2463\/mrms.mp.2016-0128","article-title":"Evaluating myometrial invasion in endometrial cancer: comparison of reduced field-of-view diffusion-weighted imaging and dynamic contrast-enhanced MR imaging","volume":"17","author":"Takeuchi","year":"2018","journal-title":"Magn Reson Med Sci"},{"key":"10.1136\/ijgc-2018-000036_bb0120","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ijgo.2009.02.010","article-title":"Revised FIGO staging for carcinoma of the endometrium","volume":"105","author":"Creasman","year":"2009","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1136\/ijgc-2018-000036_bb0125","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s13304-017-0419-y","article-title":"Fertility sparing surgery for stage IA type I and G2 endometrial cancer in reproductive-aged patients: evidence-based approach and future perspectives","volume":"69","author":"Vitale","year":"2017","journal-title":"Updates Surg"},{"key":"10.1136\/ijgc-2018-000036_bb0130","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1097\/AOG.0b013e3182964ce3","article-title":"Hormonal therapy for women with stage IA endometrial cancer of all grades","volume":"122","author":"Park","year":"2013","journal-title":"Obstet Gynecol"},{"key":"10.1136\/ijgc-2018-000036_bb0135","first-page":"3047","article-title":"Fertility-sparing management of grade 2 and 3 endometrial adenocarcinomas","volume":"31","author":"Koskas","year":"2011","journal-title":"Anticancer Res"},{"issue":"Suppl 4","key":"10.1136\/ijgc-2018-000036_bb0140","doi-asserted-by":"crossref","first-page":"iv153","DOI":"10.1093\/annonc\/mdx243","article-title":"Appendix 5: Endometrial cancer: eUpdate published online 8 June 2017 (www.esmo.org\/Guidelines\/Gynaecological-Cancers)","volume":"28","author":"Colombo","year":"2017","journal-title":"Ann Oncol"},{"key":"10.1136\/ijgc-2018-000036_bb0145","doi-asserted-by":"crossref","first-page":"358.e1","DOI":"10.1016\/j.ajog.2013.06.031","article-title":"Combined medroxyprogesterone acetate\/levonorgestrel-intrauterine system treatment in young women with early-stage endometrial cancer","volume":"209","author":"Kim","year":"2013","journal-title":"Am J Obstet Gynecol"},{"key":"10.1136\/ijgc-2018-000036_bb0150","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1634\/theoncologist.2013-0445","article-title":"Progestins in the fertility-sparing treatment and retreatment of patients with primary and recurrent endometrial cancer","volume":"20","author":"Park","year":"2015","journal-title":"Oncologist"},{"key":"10.1136\/ijgc-2018-000036_bb0155","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1097\/IGC.0000000000000825","article-title":"Long-term oncologic and reproductive outcomes in young women with early endometrial cancer conservatively treated: a prospective study and literature update","volume":"26","author":"Laurelli","year":"2016","journal-title":"Int J Gynecol Cancer"},{"key":"10.1136\/ijgc-2018-000036_bb0160","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1007\/s11095-006-9104-4","article-title":"A review of poloxamer 407 pharmaceutical and pharmacological characteristics","volume":"23","author":"Dumortier","year":"2006","journal-title":"Pharm Res"},{"key":"10.1136\/ijgc-2018-000036_bb0165","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1007\/s10856-016-5773-7","article-title":"Anti-adhesive effect of poloxamer-based thermo-sensitive sol-gel in rabbit laminectomy model","volume":"27","author":"Shin","year":"2016","journal-title":"J Mater Sci Mater Med"},{"key":"10.1136\/ijgc-2018-000036_bb0170","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.thromres.2011.10.007","article-title":"Plasminogen activator inhibitor-1 (PAI-1) 4 G\/5 G polymorphism and endometrial cancer. Influence of PAI-1 polymorphism on tissue PAI-1 antigen and mRNA expression and tumor severity","volume":"130","author":"Gilabert-Estell\u00e9s","year":"2012","journal-title":"Thromb Res"},{"key":"10.1136\/ijgc-2018-000036_bb0175","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1006\/gyno.1997.4751","article-title":"Tumor-associated proteolytic factors uPA and PAI-1 in endometrial carcinoma","volume":"66","author":"K\u00f6hler","year":"1997","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2018-000036_bb0180","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1007\/s10528-017-9796-7","article-title":"The association of plasminogen activator inhibitor type 1 (PAI-1) level and PAI-1 4G\/5G gene polymorphism with the formation and the grade of endometrial cancer","volume":"55","author":"Y\u0131ld\u0131r\u0131m","year":"2017","journal-title":"Biochem Genet"},{"key":"10.1136\/ijgc-2018-000036_bb0185","first-page":"1153","article-title":"The effect of trombophilia on pregnancy outcome and IVF success","volume":"38","author":"Goldstajn","year":"2014","journal-title":"Coll Antropol"},{"key":"10.1136\/ijgc-2018-000036_bb0190","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1111\/IGC.0b013e3181e94f5a","article-title":"Fertility-sparing therapy in young women with endometrial cancer: 2010 update","volume":"20","author":"Erkanli","year":"2010","journal-title":"Int J Gynecol Cancer"},{"key":"10.1136\/ijgc-2018-000036_bb0195","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.ygyno.2013.06.035","article-title":"Comparison of dilatation & curettage and endometrial aspiration biopsy accuracy in patients treated with high-dose oral progestin plus levonorgestrel intrauterine system for early-stage endometrial cancer","volume":"130","author":"Kim","year":"2013","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2018-000036_bb0200","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1006\/jsre.2001.6248","article-title":"Prevention of postsurgical adhesions with an autocrosslinked hyaluronan derivative gel","volume":"100","author":"Belluco","year":"2001","journal-title":"J Surg Res"},{"key":"10.1136\/ijgc-2018-000036_bb0205","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.ejca.2012.09.017","article-title":"Long-term oncologic outcomes after fertility-sparing management using oral progestin for young women with endometrial cancer (KGOG 2002)","volume":"49","author":"Park","year":"2013","journal-title":"Eur J Cancer"},{"key":"10.1136\/ijgc-2018-000036_bb0210","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.ygyno.2012.01.003","article-title":"Oncologic and reproductive outcomes with progestin therapy in women with endometrial hyperplasia and grade 1 adenocarcinoma: a systematic review","volume":"125","author":"Gunderson","year":"2012","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2018-000036_bb0215","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1097\/IGC.0000000000000927","article-title":"Combined oral medroxyprogesterone\/levonorgestrel-intrauterine system treatment for women with grade 2 stage IA endometrial cancer","volume":"27","author":"Hwang","year":"2017","journal-title":"Int J Gynecol Cancer"},{"key":"10.1136\/ijgc-2018-000036_bb0220","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.ygyno.2016.04.008","article-title":"Progesterone receptor expression is associated with longer overall survival within high-grade histotypes of endometrial carcinoma: a Canadian high risk endometrial cancer consortium (CHREC) study","volume":"141","author":"K\u00f6bel","year":"2016","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2018-000036_bb0225","first-page":"215","article-title":"Expression of ER, PR, and Her-2\/neu in endometrial cancer: a clinicopathological study","volume":"11","author":"Srijaipracharoen","year":"2010","journal-title":"Asian Pac J Cancer Prev"},{"key":"10.1136\/ijgc-2018-000036_bb0230","doi-asserted-by":"crossref","first-page":"194.e1","DOI":"10.1016\/j.ajog.2009.05.003","article-title":"Clinical factors affecting the diagnostic accuracy of assessing dilation and curettage vs frozen section specimens for histologic grade and depth of myometrial invasion in endometrial carcinoma","volume":"201","author":"Wang","year":"2009","journal-title":"Am J Obstet Gynecol"}],"container-title":["International Journal of Gynecological Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24010570?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24010570?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ijgc-2018-000036","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T01:23:18Z","timestamp":1753233798000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1048891X24010570"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["S1048891X24010570"],"URL":"https:\/\/doi.org\/10.1136\/ijgc-2018-000036","relation":{},"ISSN":["1048-891X"],"issn-type":[{"value":"1048-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pregnancy and oncologic outcomes after fertility-sparing management for early stage endometrioid endometrial cancer","name":"articletitle","label":"Article Title"},{"value":"International Journal of Gynecological Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ijgc-2018-000036","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2019 IGCS and ESGO 2019. No commercial re-use. See rights and permissions. Published by BMJ.","name":"copyright","label":"Copyright"}]}}